Navigation Links
Bioscience Bridge, LLC Launches as a Technology Transfer Agency for University-Based Bioscience Research
Date:3/17/2010

BOISE, Idaho, March 17 /PRNewswire/ -- A new professional services company has been launched focused on accelerating the connections of university-based bioscience research with commercial development opportunities. Bioscience Bridge, LLC was formed by Michelle Travis, principal and managing director, along with Mark Stinson, chief strategic officer.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20100317/CG72294LOGO)

Bioscience Bridge is also supported by a team of consultants with experience in product strategy, marketing, business development, life science, legal, licensing and commercialization.

According to Ms. Travis, "We know that some of the best bioscience research comes from universities. Bioscience Bridge helps tech transfer offices at these universities get the technology out into the marketplace. This may be in the form of a start-up company or licensing agreements."

She adds, "We have the industry experience to bring the right companies to the universities."

University offices of technology transfer (OTT) have contacted Bioscience Bridge when they have a technology that is "stuck" or are looking for a technology portfolio evaluation.

Bioscience Bridge has several proprietary processes to assist OTTs:

  • Evaluation – using B.E.A.M.S.® to analyze university's specific technology or entire portfolio
  • Strategy – facilitating a Strategic GPS® to guide early stage technologies
  • Promotion – getting the right message in the right medium to the right people
  • Negotiation – assisting with the contract terms process leading to commercial agreements

Bioscience Bridge works with universities and life science companies around the world. They will be attending the AUTM 2010 Annual Meeting in New Orleans March 18-21, BIO International 2010 in Chicago May 3-6, and the Licensing Executives Society Spring Meeting in Boston, May 19-21. More information about Bioscience Bridge services, capabilities, and connections is online at www.biosciencebridge.com

About Bioscience Bridge, LLC:

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we support tech transfer offices with our bioscience industry experience and a proven process in the evaluation, strategy, promotion and negotiation of licensing, collaboration or start up arrangements. The agency is a member of Association of Technology Managers (AUTM) and the Licensing Executives Society (LES). More information is on the Bioscience Bridge website at www.biosciencebridge.com

SOURCE Bioscience Bridge, LLC

Back to top

RELATED LINKS
http://www.biosciencebridge.com

'/>"/>

SOURCE Bioscience Bridge, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
2. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
3. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
4. YM BioSciences closes US$17.5 million financing
5. YM BioSciences to raise approximately US$15 million
6. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
7. TEI Biosciences PriMatrix(TM) Awarded Seal of Approval by American Podiatric Medical Association
8. KGI Study Reveals Diverse and Vibrant Regional Bioscience Industry
9. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
10. YM BioSciences granted two US patents for AeroLEF(R)
11. Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf ... join the faculty of the University of North Carolina Kenan-Flagler Business School ... and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s international efforts, ...
(Date:6/24/2016)... , June 24, 2016  Regular discussions on a ... take place between the two entities said Poloz. ... Ottawa , he pointed to the country,s ... the federal government. ... said, "Both institutions have common economic goals, why not sit ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Researchers at the ... commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject ... it now. , Diagnostic biomarkers are signposts in the blood, lung fluid or ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):